These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23911110)

  • 21. Lithium treatment of a bipolar patient with Wilson's disease: a case report.
    Rybakowski JK; Litwin T; Chlopocka-Wozniak M; Czlonkowska A
    Pharmacopsychiatry; 2013 May; 46(3):120-1. PubMed ID: 23037949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6).
    Licht RW; Nielsen JN; Gram LF; Vestergaard P; Bendz H
    Bipolar Disord; 2010 Aug; 12(5):483-93. PubMed ID: 20712749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lithium augmentation of topiramate for bipolar disorder with comorbid binge eating disorder and obesity.
    Kotwal R; Guerdjikova A; McElroy SL; Keck PE
    Hum Psychopharmacol; 2006 Oct; 21(7):425-31. PubMed ID: 16941522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Has the effectiveness of lithium changed? Impact of the variety of lithium's effects.
    Grof P
    Neuropsychopharmacology; 1998 Sep; 19(3):183-8. PubMed ID: 9653705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
    J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications.
    Baldessarini RJ; Tondo L; Viguera AC
    Bipolar Disord; 1999 Sep; 1(1):17-24. PubMed ID: 11256650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of refractoriness to lithium therapy following its discontinuation in a previously responsive patient.
    Appleby B; Wise T; Isaac A
    Harv Rev Psychiatry; 2006; 14(6):330-2. PubMed ID: 17162656
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.
    van der Loos ML; Mulder P; Hartong EG; Blom MB; Vergouwen AC; van Noorden MS; Timmermans MA; Vieta E; Nolen WA;
    Bipolar Disord; 2011 Feb; 13(1):111-7. PubMed ID: 21320258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk of inducing resistance upon stopping and restarting lithium after long-term usage].
    Collumbien EC
    Ned Tijdschr Geneeskd; 2000 May; 144(21):1022-3. PubMed ID: 10858795
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination.
    Masi G; Perugi G; Millepiedi S; Mucci M; Pfanner C; Berloffa S; Pari C; Gagliano A; D'Amico F; Akiskal HS
    Psychiatry Res; 2010 May; 177(1-2):192-8. PubMed ID: 20381170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium.
    Marmol F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1761-71. PubMed ID: 18789369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
    Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M
    Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium maintenance therapy for bipolar I patients: possible refractoriness to reinstitution after discontinuation.
    Murray JB
    Psychol Rep; 1994 Apr; 74(2):355-61. PubMed ID: 8197273
    [No Abstract]   [Full Text] [Related]  

  • 35. The impact of lithium long-term medication on suicidal behavior and mortality of bipolar patients.
    Müller-Oerlinghausen B; Felber W; Berghöfer A; Lauterbach E; Ahrens B
    Arch Suicide Res; 2005; 9(3):307-19. PubMed ID: 16020173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced morbidity after gradual discontinuation of lithium treatment for bipolar I and II disorders: a replication study.
    Baldessarini RJ; Tondo L; Floris G; Rudas N
    Am J Psychiatry; 1997 Apr; 154(4):551-3. PubMed ID: 9090345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired lithium resistance revisited: discontinuation-induced refractoriness versus tolerance.
    Post RM
    J Affect Disord; 2012 Sep; 140(1):6-13. PubMed ID: 22154708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylaxis of bipolar disorder: how and who should we treat in the long term?
    Goodwin GM
    Eur Neuropsychopharmacol; 1999 Aug; 9 Suppl 4():S125-9. PubMed ID: 10524839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From BALANCE to DSM-5: taking lithium seriously.
    Ghaemi SN
    Bipolar Disord; 2010 Nov; 12(7):673-7. PubMed ID: 21066907
    [No Abstract]   [Full Text] [Related]  

  • 40. Lithium-associated anencephaly.
    Grover S; Gupta N
    Can J Psychiatry; 2005 Mar; 50(3):185-6. PubMed ID: 15830831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.